HAVAS NV (HAVAS.AS) Fundamental Analysis & Valuation

AMS:HAVAS • NL0015002K83

Current stock price

15.116 EUR
+0.2 (+1.31%)
Last:

This HAVAS.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. HAVAS.AS Profitability Analysis

1.1 Basic Checks

  • HAVAS had positive earnings in the past year.
  • HAVAS had a positive operating cash flow in the past year.
  • HAVAS had positive earnings in 4 of the past 5 years.
  • Of the past 5 years HAVAS 4 years had a positive operating cash flow.
HAVAS.AS Yearly Net Income VS EBIT VS OCF VS FCFHAVAS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • HAVAS has a Return On Assets (2.65%) which is in line with its industry peers.
  • The Return On Equity of HAVAS (10.20%) is better than 66.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.89%, HAVAS belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
Industry RankSector Rank
ROA 2.65%
ROE 10.2%
ROIC 9.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAVAS.AS Yearly ROA, ROE, ROICHAVAS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • With a decent Profit Margin value of 6.06%, HAVAS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • HAVAS's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 11.77%, HAVAS is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • HAVAS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.77%
PM (TTM) 6.06%
GM N/A
OM growth 3Y2.56%
OM growth 5YN/A
PM growth 3Y1.61%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HAVAS.AS Yearly Profit, Operating, Gross MarginsHAVAS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HAVAS.AS Health Analysis

2.1 Basic Checks

  • HAVAS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for HAVAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HAVAS.AS Yearly Shares OutstandingHAVAS.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
HAVAS.AS Yearly Total Debt VS Total AssetsHAVAS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • HAVAS has an Altman-Z score of 0.34. This is a bad value and indicates that HAVAS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of HAVAS (0.34) is worse than 77.27% of its industry peers.
  • The Debt to FCF ratio of HAVAS is 3.13, which is a good value as it means it would take HAVAS, 3.13 years of fcf income to pay off all of its debts.
  • HAVAS has a Debt to FCF ratio of 3.13. This is in the better half of the industry: HAVAS outperforms 74.24% of its industry peers.
  • HAVAS has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.14, HAVAS belongs to the best of the industry, outperforming 80.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 3.13
Altman-Z 0.34
ROIC/WACC1.29
WACC7.67%
HAVAS.AS Yearly LT Debt VS Equity VS FCFHAVAS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • HAVAS has a Current Ratio of 0.83. This is a bad value and indicates that HAVAS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HAVAS has a Current ratio of 0.83. This is in the lower half of the industry: HAVAS underperforms 60.61% of its industry peers.
  • HAVAS has a Quick Ratio of 0.83. This is a bad value and indicates that HAVAS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HAVAS has a Quick ratio of 0.80. This is comparable to the rest of the industry: HAVAS outperforms 43.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.8
HAVAS.AS Yearly Current Assets VS Current LiabilitesHAVAS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HAVAS.AS Growth Analysis

3.1 Past

  • HAVAS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.67%.
  • HAVAS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -21.90% yearly.
  • Looking at the last year, HAVAS shows a very strong growth in Revenue. The Revenue has grown by 50.93%.
  • The Revenue has been growing slightly by 1.75% on average over the past years.
EPS 1Y (TTM)-2.67%
EPS 3Y-21.9%
EPS 5YN/A
EPS Q2Q%85.26%
Revenue 1Y (TTM)50.93%
Revenue growth 3Y1.75%
Revenue growth 5YN/A
Sales Q2Q%94.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.95% on average over the next years.
  • HAVAS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.95% yearly.
EPS Next Y9.23%
EPS Next 2Y8.33%
EPS Next 3Y7.83%
EPS Next 5Y2.95%
Revenue Next Year2.05%
Revenue Next 2Y2.18%
Revenue Next 3Y2.07%
Revenue Next 5Y0.95%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HAVAS.AS Yearly Revenue VS EstimatesHAVAS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
HAVAS.AS Yearly EPS VS EstimatesHAVAS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. HAVAS.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 5.70, the valuation of HAVAS can be described as very cheap.
  • HAVAS's Price/Earnings ratio is rather cheap when compared to the industry. HAVAS is cheaper than 86.36% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of HAVAS to the average of the S&P500 Index (25.23), we can say HAVAS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 6.76, the valuation of HAVAS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, HAVAS is valued cheaper than 83.33% of the companies in the same industry.
  • HAVAS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.7
Fwd PE 6.76
HAVAS.AS Price Earnings VS Forward Price EarningsHAVAS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • HAVAS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HAVAS is cheaper than 81.82% of the companies in the same industry.
  • HAVAS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HAVAS is cheaper than 78.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.46
EV/EBITDA 3.96
HAVAS.AS Per share dataHAVAS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y8.33%
EPS Next 3Y7.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. HAVAS.AS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.38%, HAVAS is a good candidate for dividend investing.
  • HAVAS's Dividend Yield is a higher than the industry average which is at 3.53.
  • HAVAS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 5.38%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
HAVAS.AS Yearly Dividends per shareHAVAS.AS Yearly Dividends per shareYearly Dividends per share 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2Y8.33%
EPS Next 3Y7.83%
HAVAS.AS Yearly Income VS Free CF VS DividendHAVAS.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 2025 100M 200M 300M

More info and screens

Find the best dividend stocksShow peers with best dividend

HAVAS.AS Fundamentals: All Metrics, Ratios and Statistics

HAVAS NV

AMS:HAVAS (3/23/2026, 5:29:59 PM)

15.116

+0.2 (+1.31%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-17
Earnings (Next)04-14
Inst Owners27.49%
Inst Owner ChangeN/A
Ins Owners2.67%
Ins Owner ChangeN/A
Market Cap1.50B
Revenue(TTM)4.32B
Net Income(TTM)176.00M
Analysts83.75
Price Target20.43 (35.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.38%
Yearly Dividend2.53
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)6.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.42%
EPS NY rev (3m)-0.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 5.7
Fwd PE 6.76
P/S 0.52
P/FCF 6.46
P/OCF 5.59
P/B 0.87
P/tB N/A
EV/EBITDA 3.96
EPS(TTM)2.65
EY17.53%
EPS(NY)2.24
Fwd EY14.79%
FCF(TTM)2.34
FCFY15.47%
OCF(TTM)2.7
OCFY17.88%
SpS29.29
BVpS17.39
TBVpS-8.16
PEG (NY)0.62
PEG (5Y)N/A
Graham Number32.2
Profitability
Industry RankSector Rank
ROA 2.65%
ROE 10.2%
ROCE 14.38%
ROIC 9.89%
ROICexc 11.66%
ROICexgc N/A
OM 11.77%
PM (TTM) 6.06%
GM N/A
FCFM 7.99%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y2.56%
OM growth 5YN/A
PM growth 3Y1.61%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 3.13
Debt/EBITDA 0.51
Cap/Depr 32.43%
Cap/Sales 1.24%
Interest Coverage 7.6
Cash Conversion 59.16%
Profit Quality 131.82%
Current Ratio 0.83
Quick Ratio 0.8
Altman-Z 0.34
F-Score8
WACC7.67%
ROIC/WACC1.29
Cap/Depr(3y)33.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.21%
Cap/Sales(5y)N/A
Profit Quality(3y)158.83%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.67%
EPS 3Y-21.9%
EPS 5YN/A
EPS Q2Q%85.26%
EPS Next Y9.23%
EPS Next 2Y8.33%
EPS Next 3Y7.83%
EPS Next 5Y2.95%
Revenue 1Y (TTM)50.93%
Revenue growth 3Y1.75%
Revenue growth 5YN/A
Sales Q2Q%94.59%
Revenue Next Year2.05%
Revenue Next 2Y2.18%
Revenue Next 3Y2.07%
Revenue Next 5Y0.95%
EBIT growth 1Y9.15%
EBIT growth 3Y4.36%
EBIT growth 5YN/A
EBIT Next Year33.14%
EBIT Next 3Y13.14%
EBIT Next 5Y7.8%
FCF growth 1Y57.21%
FCF growth 3Y-0.6%
FCF growth 5YN/A
OCF growth 1Y50%
OCF growth 3Y-0.63%
OCF growth 5YN/A

HAVAS NV / HAVAS.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HAVAS NV?

ChartMill assigns a fundamental rating of 5 / 10 to HAVAS.AS.


What is the valuation status of HAVAS NV (HAVAS.AS) stock?

ChartMill assigns a valuation rating of 8 / 10 to HAVAS NV (HAVAS.AS). This can be considered as Undervalued.


Can you provide the profitability details for HAVAS NV?

HAVAS NV (HAVAS.AS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for HAVAS stock?

The Price/Earnings (PE) ratio for HAVAS NV (HAVAS.AS) is 5.7 and the Price/Book (PB) ratio is 0.87.


What is the financial health of HAVAS NV (HAVAS.AS) stock?

The financial health rating of HAVAS NV (HAVAS.AS) is 3 / 10.